The DNA Helicase Recql4 Is Required for Normal Osteoblast Expansion and Osteosarcoma Formation

RECQL4 mutations are associated with Rothmund Thomson Syndrome (RTS), RAPADILINO Syndrome and Baller-Gerold Syndrome. These patients display a range of benign skeletal abnormalities such as low bone mass. In addition, RTS patients have a highly increased incidence of osteosarcoma (OS). The role of RECQL4 in normal adult bone development and homeostasis is largely uncharacterized and how mutation of RECQL4 contributes to OS susceptibility is not known. We hypothesised that Recql4 was required for normal skeletal development and both benign and malignant osteoblast function, which we have tested in the mouse. Recql4 deletion in vivo at the osteoblastic progenitor stage of differentiation resulted in mice with shorter bones and reduced bone volume, assessed at 9 weeks of age. This was associated with an osteoblast intrinsic decrease in mineral apposition rate and bone formation rate in the Recql4-deficient cohorts. Deletion of Recql4 in mature osteoblasts/osteocytes in vivo, however, did not cause a detectable phenotype. Acute deletion of Recql4 in primary osteoblasts or shRNA knockdown in an osteoblastic cell line caused failed proliferation, accompanied by cell cycle arrest, induction of apoptosis and impaired differentiation. When cohorts of animals were aged long term, the loss of Recql4 alone was not sufficient to initiate OS. We then crossed the Recql4fl/fl allele to a fully penetrant OS model (Osx-Cre p53fl/fl). Unexpectedly, the Osx-Cre p53fl/flRecql4fl/fl (dKO) animals had a significantly increased OS-free survival compared to Osx-Cre p53fl/fl or Osx-Cre p53fl/flRecql4fl/+ (het) animals. The extended survival was explained when the Recql4 status in the tumors that arose was assessed, and in no case was there complete deletion of Recql4 in the dKO OS. These data provide a mechanism for the benign skeletal phenotypes of RECQL4 mutation syndromes. We propose that tumor suppression and osteosarcoma susceptibility are most likely a function of mutant, not null, alleles of RECQL4.

[1]  B. Dawson,et al.  RECQL4 Regulates p53 Function In Vivo During Skeletogenesis , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Adam Kiezun,et al.  Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma , 2014, Proceedings of the National Academy of Sciences.

[3]  T. Martin,et al.  EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  A. Chalk,et al.  The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis. , 2014, The Journal of clinical investigation.

[5]  K. Becker,et al.  Senescence induced by RECQL4 dysfunction contributes to Rothmund–Thomson syndrome features in mice , 2014, Cell Death and Disease.

[6]  Li Ding,et al.  Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. , 2014, Cell reports.

[7]  C. Bradshaw,et al.  Titration of Four Replication Factors Is Essential for the Xenopus laevis Midblastula Transition , 2013, Science.

[8]  R. Brosh DNA helicases involved in DNA repair and their roles in cancer , 2013, Nature Reviews Cancer.

[9]  A. Chalk,et al.  Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA. , 2013, Bone.

[10]  C. Chiang,et al.  Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual , 2012, Transgenic Research.

[11]  S. Gagos,et al.  The helicase domain and C-terminus of human RecQL4 facilitate replication elongation on DNA templates damaged by ionizing radiation. , 2012, Carcinogenesis.

[12]  N. Lindor,et al.  RECQL4 is essential for the transport of p53 to mitochondria in normal human cells in the absence of exogenous stress , 2012, Journal of Cell Science.

[13]  Charles P. Lin,et al.  Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. , 2012, Cell stem cell.

[14]  C. Gibbs,et al.  Treatment of Bone Tumors. , 2012, Surgical pathology clinics.

[15]  Jinhu Xiong,et al.  Matrix-embedded cells control osteoclast formation , 2011, Nature Medicine.

[16]  T. Martin,et al.  Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. , 2011, Blood.

[17]  F. Mseeh,et al.  Lrp5 functions in bone to regulate bone mass , 2011, Nature Medicine.

[18]  M. Seki,et al.  The N-terminal region of RECQL4 lacking the helicase domain is both essential and sufficient for the viability of vertebrate cells. Role of the N-terminal region of RECQL4 in cells. , 2011, Biochimica et biophysica acta.

[19]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[20]  R. Monnat Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. , 2010, Seminars in cancer biology.

[21]  S. Plon,et al.  The involvement of human RECQL4 in DNA double‐strand break repair , 2010, Aging cell.

[22]  F. Berthold,et al.  Multiple malignant diseases in a patient with Rothmund–Thomson syndrome with RECQL4 mutations: Case report and literature review , 2010, American journal of medical genetics. Part A.

[23]  L. Larizza,et al.  Rothmund-Thomson syndrome , 2010, Orphanet journal of rare diseases.

[24]  P. Lin,et al.  Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice. , 2009, Carcinogenesis.

[25]  Ian D. Hickson,et al.  RecQ helicases: multifunctional genome caretakers , 2009, Nature Reviews Cancer.

[26]  Lisa Mirabello,et al.  International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons , 2009, International journal of cancer.

[27]  D. Burr,et al.  Osteoblast Function Is Compromised at Sites of Focal Bone Erosion in Inflammatory Arthritis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  J. Squire,et al.  Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma. , 2009, Neoplasia.

[29]  R. Hennekam,et al.  The mutation spectrum in RECQL4 diseases , 2009, European Journal of Human Genetics.

[30]  M. Bouxsein,et al.  Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage , 2008, Proceedings of the National Academy of Sciences.

[31]  F. Alt,et al.  Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. , 2008, Genes & development.

[32]  Kyucheol Cho,et al.  Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix , 2008, Proceedings of the National Academy of Sciences.

[33]  S. Orkin,et al.  Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow Microenvironment , 2007, Cell.

[34]  L. Bonewald,et al.  DMP1-targeted Cre Expression in Odontoblasts and Osteocytes , 2007, Journal of dental research.

[35]  A. McMahon,et al.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors , 2006, Development.

[36]  A. Prahalad,et al.  Recql4 haploinsufficiency in mice leads to defects in osteoblast progenitors: Implications for low bone mass phenotype. , 2006, Biochemical and biophysical research communications.

[37]  Stephen N. Jones,et al.  Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling , 2006, The Journal of cell biology.

[38]  D. Link,et al.  G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. , 2005, Blood.

[39]  Michael B. Mann,et al.  Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome. , 2005, Human molecular genetics.

[40]  L. Peltonen,et al.  Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases. , 2003, Human molecular genetics.

[41]  T. Ohhata,et al.  Growth retardation and skin abnormalities of the Recql4-deficient mouse. , 2003, Human molecular genetics.

[42]  T. Martin,et al.  Differentiation potential of a mouse bone marrow stromal cell line , 2003, Journal of cellular biochemistry.

[43]  E. Zackai,et al.  Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. , 2003, Journal of the National Cancer Institute.

[44]  Bom-taeck Kim,et al.  The Structural and Hormonal Basis of Sex Differences in Peak Appendicular Bone Strength in Rats , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  N. Jaffe,et al.  Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? , 2002, Cancer.

[46]  K. Worley,et al.  Intron-size constraint as a mutational mechanism in Rothmund-Thomson syndrome. , 2002, American journal of human genetics.

[47]  T. Noda,et al.  [Preparation of the gene targeted knockout mice for human premature aging diseases, Werner syndrome, and Rothmund-Thomson syndrome caused by the mutation of DNA helicases]. , 2002, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[48]  D. Lev,et al.  Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. , 2001, American journal of medical genetics.

[49]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[50]  R. Baron,et al.  Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. , 2000, The Journal of clinical investigation.

[51]  N. Lindor,et al.  Rothmund-thomson syndrome responsible gene, RECQL4: genomic structure and products. , 1999, Genomics.

[52]  M. Ladanyi,et al.  Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone , 1997, Sarcoma.

[53]  H. Snoeck,et al.  Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-Sca-1 monoclonal antibody and wheat germ agglutinin , 1994 .

[54]  Hao Liu,et al.  RECQ DNA helicases and osteosarcoma. , 2014, Advances in experimental medicine and biology.

[55]  S. Sengupta,et al.  RECQL4 and p53 potentiate the activity of polymerase γ and maintain the integrity of the human mitochondrial genome. , 2014, Carcinogenesis.

[56]  H. Snoeck,et al.  Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-Sca-1 monoclonal antibody and wheat germ agglutinin. , 1994, Blood.